Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication ofHelicobacter pylori | Zendy

Raymond Lahaie | Zendy; Alain Farley | Zendy; Chrystian Dallaire | Zendy; André Archambault | Zendy; Carlo A Fallone | Zendy; Terry Ponich | Zendy; Richard H. Hunt | Zendy; Michael Oravec | Zendy; Paul Whitsitt | Zendy; Sander Veldhuyzen van Zanten | Zendy; Norman E. Marcon | Zendy; Robert J. Bailey | Zendy; André Dumont | Zendy; Bich Nguyen | Zendy; Sylvain Desrochers | Zendy; Jean Spénard | Zendy

Open Access

Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication ofHelicobacter pylori

Author(s) -

Raymond Lahaie,

Alain Farley,

Chrystian Dallaire,

André Archambault,

Carlo A Fallone,

Terry Ponich,

Richard H. Hunt,

Michael Oravec,

Paul Whitsitt,

Sander Veldhuyzen van Zanten,

Norman E. Marcon,

Robert J. Bailey,

André Dumont,

Bich Nguyen,

Sylvain Desrochers,

Jean Spénard

Publication year - 2001

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2001/305756

Subject(s) - metronidazole , omeprazole , helicobacter pylori , medicine , gastroenterology , tetracycline , urea breath test , regimen , antibiotics , breath test , microbiology and biotechnology , biology , helicobacter pylori infection

A previous study showed that 14 days of qid bismuth-based triple therapy with tetracycline 500 mg, metronidazole 250 mg and colloidal bismuth subcitrate 120 mg resulted in excellent Helicobacter pylori eradication rates (89.5%). The present study looked at a shorter treatment period by adding omeprazole and by reducing the dose of tetracycline.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research